In vivo efficiency of the produced recombinant lysostaphin antimicrobial peptide in treatment of methicillin-resistant Staphylococcus aureus (MRSA) skin infection in a mouse model
Sign Up to like & getrecommendations! Published in 2023 at "Iranian Journal of Microbiology"
DOI: 10.18502/ijm.v15i2.12476
Abstract: Background and Objectives: Staphylococcus simulans secretes an antimicrobial compound called lysostaphin, which has bactericidal properties. It destroys staphylococci through the hydrolysis of peptidoglycan in the cell wall. Therefore, this unique property indicates the high ability… read more here.
Keywords: recombinant lysostaphin; staphylococcus aureus; model; treatment ... See more keywords